Answers are grounded in this paper and cite their sources.
Policy review examines emerging governance frameworks for AI clinical tools using diabetes care as an exemplar, highlighting critical priorities for regulation and reimbursement.
A U.S. Department of Health and Human Services Request for Information seeks input on “Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care.” This solicitation could impact future policies on regulation, reimbursement, and research, with emphasis on AI governance and implementation science. Using diabetes as an exemplar, this article examines emerging frameworks for AI‑enabled tools for continuous glucose monitoring, automated insulin delivery, and clinical decision support.
No takes yet. Share an insight, caveat, or question.
Klonoff et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: